Abstract
Hematopoiesis is the highly regulated and complex process by which blood cells are formed. Hematopoiesis can be achieved in vitro by the differentiation of embryonic stem cells (ESCs) into hematopoietic lineage cells. Differentiation of ESCs initially gives rise to mesoderm colonies that go on to form hemangioblast cells, which possess endothelial and hematopoietic lineage potential. While the differentiation of several hematopoietic lineages from ESCs, such as erythrocytes and macrophages, can be easily recapitulated in vitro, T-cell differentiation requires additional Notch-dependent signals for their generation. Keeping with this, ESCs induced to differentiate with OP-9 cells, a bone marrow-derived stromal cell line, give rise to erythro-myeloid cells and B lymphocytes, while the expression of an appropriate Notch ligand, such as Delta-like 1, on OP-9 cells (OP9-DL1) is required to support the generation of T-cells in vitro. Here, we describe an updated and streamlined protocol for the generation of T-lineage cells from mouse ESCs cultured on OP9-DL1 cells. This approach can facilitate studies aimed to assess the effects of environmental and genetic manipulations at various stages of T-cell development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Robertson EJ (1987) Teratocarcinomas and embryonic stem cells: a practical approach. IRL, Oxford, UK
Chen U, Kosco M, Staerz U (1992) Establishment and characterization of lymphoid and myeloid mixed-cell populations from mouse late embryoid bodies “embryonic-stem-cell fetuses”. Proc Natl Acad Sci USA89:2541–2545
Gutierrez-Ramos JC, Palacios R (1992) In vitro differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in vivo. Proc Natl Acad Sci USA89:9171–9175
Potocnik AJ, Nielsen PJ, Eichmann K (1994) In vitro generation of lymphoid precursors from embryonic stem cells. EMBO J 13:5274–5283
Burt RK, Verda L, Kim DA, Oyama Y, Luo K, Link C (2004) Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J Exp Med 199:895–904
Nakano T (1995) Lymphohematopoietic development from embryonic stem cells in vitro. Semin Immunol 7:197–203
Nakano T, Kodama H, Honjo T (1994) Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265:1098–1101
Yoshida H, Hayashi S, Kunisada T et al (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442–444
Cho SK, Webber TD, Carlyle JR et al (1999) Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc Natl Acad Sci USA96:9797–9802
Hirayama F, Lyman SD, Clark SC, Ogawa M (1995) The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood 85: 1762–1768
Hudak S, Hunte B, Culpepper J et al (1995) FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood 85:2747–2755
Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D (1996) flk2/flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors. J Immunol 156:489–496
Jacobsen SE, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD (1995) The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors. J Exp Med 181:1357–1363
Lyman SD, Jacobsen SE (1998) c-kit ligand and Flt3 Ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101–1134
Veiby OP, Lyman SD, Jacobsen SEW (1996) Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood 88: 1256–1265
Pui JC, Allman D, Xu L et al (1999) Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11:299–308
Radtke F, Wilson A, Stark G et al (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547–558
de Pooter RF, Cho SK, Carlyle JR, Zúñiga-Pflücker JC (2003) In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood 102: 1649–1653
Schmitt TM, Zúñiga-Pflücker JC (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749–756
Schmitt TM, de Pooter RF, Gronski MA et al (2004) Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol 5:410–417
Zúñiga-Pflücker JC (2004) T-cell development made simple. Nat Rev Immunol 4(1):67–72
Robertson EJ (1997) Derivation and maintenance of embryonic stem cell cultures. Methods Mol Biol 75:173–184
de Pooter RF, Cho SK, Zúñiga-Pflücker JC (2005) In vitro generation of lymphocytes from embryonic stem cells. Methods Mol Biol 290:135–147
Holmes R, Zúñiga-Pflücker JC (2009) The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb Protoc Pdb.prot5156 DOI:10.1101/pdb.prot5156.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Liang, H.CY., Holmes, R., Zúñiga-Pflücker, J.C. (2013). Directed Differentiation of Embryonic Stem Cells to the T-Lymphocyte Lineage. In: Zavazava, N. (eds) Embryonic Stem Cell Immunobiology. Methods in Molecular Biology, vol 1029. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-478-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-478-4_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-477-7
Online ISBN: 978-1-62703-478-4
eBook Packages: Springer Protocols